Medically reviewed by David Ozeri, MD Focal segmental glomerulosclerosis (FSGS) describes a condition in which scarring damages some of your kidneys' glomeruli, the microscopic filters that help your ...

Medically reviewed by Alexis Appelstein, DO There is no cure for focal segmental glomerulosclerosis (FSGS), but the proper ...

Travere Therapeutics Inc. (NASDAQ:TVTX) is one of the best small cap stocks with biggest upside potential. On August 10, Citi ...

A new study has identified a blood-cleansing procedure known as therapeutic apheresis as a potential game-changer in kidney transplant management, raising fresh hope for patients facing transplant ...

Art in the Loft’s “SummerView” exhibit is on display now through Sept. 6 at 109 N. 2nd Ave. in Alpena. The gallery is open ...

Why Precision Funds Management's Dermot Woods takes a shine to biotechs that can explain their programs in simple terms.

After years of rocking stages across the Midwest, Alpena’s own Katharsys Theory has announced their final performance will ...

With a solid cash position and expected profitability by late 2026, Apellis stock is set for recovery. Read the latest ...

Acadia Healthcare Company Inc. (NASDAQ: ACHC) is one of the best small cap stocks with biggest upside potential. On August 13 ...

LGND READ THE FULL LGND RESEARCH REPORT Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) reported second quarter 2025 financial and ...

Data show that diabetes-associated metabolic issues lead to kidney lipid accumulation, resulting in inflammation and fibrosis that cause progressive kidney damage and disease progression.Earlier data ...

Morgan's Scott Power highlights nine ASX healthcare companies from the 2025 Bioshares Biotech Summit with catalysts over next ...